How to buy Frequency Therapeutics stock (FREQ)

Frequency Therapeutics is a biotechnology business based in the US. Frequency Therapeutics shares (FREQ) are listed on the NASDAQ and all prices are listed in US Dollars. Frequency Therapeutics employs 46 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Frequency Therapeutics stock

Buy Frequency Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Frequency Therapeutics stock price (NASDAQ: FREQ)

Use our graph to track the performance of FREQ stocks over time.

Frequency Therapeutics shares at a glance

• Key figures

Information last updated 2023-12-24.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.35
200-day moving average more info button	$0.64
Wall St. target price	$0.50
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-1.90

Is it a good time to buy Frequency Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Frequency Therapeutics financials

Gross profit TTM	$-42,015,000
Return on assets TTM	-42.5%
Return on equity TTM	-99.93%
Profit margin	0%
Book value	$1.00
Market Capitalization more info button	$10.9 million

TTM: trailing 12 months

Frequency Therapeutics share dividends

We're not expecting Frequency Therapeutics to pay a dividend over the next 12 months.

Have Frequency Therapeutics's shares ever split?

Frequency Therapeutics's shares were split on a 1:50 basis on 5 November 2023 . So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Frequency Therapeutics shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Frequency Therapeutics shares which in turn could have impacted Frequency Therapeutics's share price.

Frequency Therapeutics share price volatility

Over the last 12 months, Frequency Therapeutics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Frequency Therapeutics's is 0.771. This would suggest that Frequency Therapeutics's shares are less volatile than average (for this exchange).

Frequency Therapeutics overview

As of November 3, 2023, Frequency Therapeutics, Inc. was acquired by Korro Bio, Inc. , in a reverse merger transaction. Frequency Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIb clinical trial to treat the underlying cause of sensorineural hearing loss.

Frequently asked questions

null
What percentage of Frequency Therapeutics is owned by insiders or institutions?
Currently 7.269% of Frequency Therapeutics shares are held by insiders and 14.121% by institutions. How many people work for Frequency Therapeutics?
Latest data suggests 46 work at Frequency Therapeutics. When does the fiscal year end for Frequency Therapeutics?
Frequency Therapeutics's fiscal year ends in December. Where is Frequency Therapeutics based?
Frequency Therapeutics's address is: 75 Hayden Avenue, Lexington, MA, United States, 02421 What is Frequency Therapeutics's ISIN number?
Frequency Therapeutics's international securities identification number is: US35803L1089 What is Frequency Therapeutics's CUSIP number?
Frequency Therapeutics's Committee on Uniform Securities Identification Procedures number is: 35803L108